TheraRadar
Data updated: Mar 29, 2026

NATROBA

SPINOSAD
Dermatology Approved 2011-01-18

NATROBA is a pediculicide indicated for the topical treatment of head lice infestations in adult and pediatric patients 6 months of age and older. ( 1.1 ) NATROBA is a scabicide indicated for the topical treatment of scabies infestations in adult and pediatric patients 4 years of age and older. ( 1.2 ) 1.1 Head Lice Infestations NATROBA is indicated for the topical treatment of head lice infestations in adult and pediatric patients 6 months of age and older. Adjunctive Measures for Head Lice Inf...

Source: FDA Label โ€ข CIPHER
3
Indications
--
Phase 3 Trials
15
Years on Market

Details

Status
Prescription
First Approved
2011-01-18
Routes
TOPICAL
Dosage Forms
SUSPENSION

Companies

Active Ingredient: SPINOSAD

NATROBA Approval History

Loading approval history...

What NATROBA Treats

2 indications

NATROBA is approved for 2 conditions since its original approval in 2011. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Head Lice Infestation
  • Scabies Infestation
Source: FDA Label
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

NATROBA FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

NATROBA is a pediculicide indicated for the topical treatment of head lice infestations in adult and pediatric patients 6 months of age and older. NATROBA is a scabicide indicated for the topical treatment of scabies infestations in adult and pediatric patients 4 years of age and older. 1.1 Head Lice Infestations NATROBA is indicated for the topical treatment of head lice infestations in adult and pediatric patients 6 months of age and older. Adjunctive Measures for Head Lice Infestations NATROBA should be used in the context of an overall lice management program: Wash in hot water or dry-clea...

NATROBA Patents & Exclusivity

Latest Patent: Nov 2033

Patents (1 active)

US9895388 Expires Nov 25, 2033
Source: FDA Orange Book

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.